Reducing alexithymia and increasing interoceptive awareness: A randomized controlled trial comparing mindfulness with dyadic socio-emotional app-based practice
Journal of Affective Disorders · 2023-11 · 341 · 162-169
DOI: 10.1016/j.jad.2023.08.093 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2023-11. Verfasst von Sarita Silveira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Social Neuroscience Lab, Max Planck Society, Berlin, Germany. Electronic address: office@social.mpg.de. Hauptthemen laut MEDLINE: Mindfulness, Mobile Applications. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Social Neuroscience Lab, Max Planck Society, Berlin, Germany. Electronic address: office@social.mpg.de.
- Social Neuroscience Lab, Max Planck Society, Berlin, Germany.
Zitieren
APA
Silveira, S., Godara, M., Faschinger, A., & Singer, T. (2023). Reducing alexithymia and increasing interoceptive awareness: A randomized controlled trial comparing mindfulness with dyadic socio-emotional app-based practice. Journal of Affective Disorders, 341, 162-169. https://doi.org/10.1016/j.jad.2023.08.093
Vancouver
Silveira S, Godara M, Faschinger A, Singer T. Reducing alexithymia and increasing interoceptive awareness: A randomized controlled trial comparing mindfulness with dyadic socio-emotional app-based practice. Journal of Affective Disorders. 2023;341:162-169. doi:10.1016/j.jad.2023.08.093
BibTeX
@article{Silveira2023,
author = {Silveira, Sarita and Godara, Malvika and Faschinger, Anna and Singer, Tania},
title = {Reducing alexithymia and increasing interoceptive awareness: A randomized controlled trial comparing mindfulness with dyadic socio-emotional app-based practice},
journal = {Journal of Affective Disorders},
year = {2023},
volume = {341},
pages = {162--169},
doi = {10.1016/j.jad.2023.08.093}
}
EUVIMED